1. Sclareol inhibits cell proliferation and sensitizes cells to the antiproliferative effect of bortezomib via upregulating the tumor suppressor caveolin-1 in cervical cancer cells
   Ting Zhang et al, 2017 CrossRef
2. Diterpenes and Their Derivatives as Potential Anticancer Agents
   Muhammad Torequl Islam, 2017, Phytother. Res. CrossRef
3. Comparative proteomic analyses of Hyphozyma roseoniger ATCC 20624 in response to sclareol
   Xiuwen Wang et al, 2018, Brazilian Journal of Microbiology CrossRef
4. null
   Nimsi Campos-Xolalpa et al, 2018 CrossRef
5. Comparative proteomic analyses of Hyphozyma roseonigra ATCC 20624 in response to sclareol
   Xiuwen Wang et al, 2019, Braz J Microbiol CrossRef
6. Sclareol-loaded hyaluronan-coated PLGA nanoparticles: Physico-chemical properties and in vitro anticancer features
   Donato Cosco et al, 2019, International Journal of Biological Macromolecules CrossRef
7. Anti-schistosomal properties of Sclareol and its Heck-coupled derivatives: design, synthesis, biological evaluation and untargeted metabolomics
   Alessandra Crusco et al, 2019, ACS Infect. Dis. CrossRef
8. Antifungal Activity and Potential Mechanism of N-Butylphthalide Alone and in Combination With Fluconazole Against Candida albicans
   Ying Gong et al, 2019, Front. Microbiol. CrossRef
9. α-Hispanolol Induces Apoptosis and Suppresses Migration and Invasion of Glioblastoma Cells Likely via Downregulation of MMP-2/9 Expression and p38MAPK Attenuation
   Vanesa Sánchez-Martín et al, 2019, Front. Pharmacol. CrossRef
10. Study of the mechanism of action, molecular docking, and dynamics of anticancer terpenoids from Salvia lachnocalyx
    Hossein Hadavand Mirzaei et al, 2020, Journal of Receptors and Signal Transduction CrossRef
11. Sclareol ameliorated ERCC1-mediated cisplatin resistance in A549 human lung adenocarcinoma cells and a murine xenograft tumor model by suppressing AKT-GSK3β-AP1/Snail and JNK-AP1 pathways
    Chun-Hsu Pan et al, 2020, Chemico-Biological Interactions CrossRef
12. GC-MS/MS method for determination and pharmacokinetics of sclareol in rat plasma after intravenous administration
    Zheng Xiang et al, 2021, Journal of Chromatography B CrossRef
13. null
    Bhawna Chopra et al, 2022 CrossRef
14. Sclareol attenuates angiotensin II ‐induced cardiac remodeling and inflammation via inhibiting MAPK signaling
    Na Yang et al, 2022, Phytotherapy Research CrossRef
15. The bioactivities of sclareol: A mini review
    Jianbo Zhou et al, 2022, Front. Pharmacol. CrossRef
16. Biosynthesis and regulation of diterpenoids in medicinal plants
    Junze REN et al, 2022, Chinese Journal of Natural Medicines CrossRef
17. Anti-Candida Potential of Sclareol in Inhibiting Growth, Biofilm Formation, and Yeast–Hyphal Transition
    Chaerim Kim et al, 2023, JoF CrossRef
18. Novel hybrids of sclareol and 1,2,4-triazolo[1,5-a]pyrimidine show collateral sensitivity in multidrug-resistant glioblastoma cells
    Pavle Stojković et al, 2023, Bioorganic Chemistry CrossRef
19. Cytotoxic Potential of Rare Plant Salvia candidissima subsp. candidissima on Breast Cancer Cells
    Elif Erturk et al, 2023, Braz. arch. biol. technol. CrossRef
20. Sclareol induces cell cycle arrest and ROS‐mediated apoptosis and ferroptosis in lung adenocarcinoma cells
    Bilal Rah et al, 2023, J Biochem & Molecular Tox CrossRef
21. Sclareol: Isolation, Structural Modification, Biosynthesis, and Pharmacological Evaluation – A Review
    Salman Jameel et al, 2024, Pharm Chem J CrossRef